\-\ Texto\\:\\ \ \(0\)\
\-\ ocular\\ exam\\:\\ papilledema\\ \\&\\ ocular\\ pressure\\ of\\ 46\\ cmh2o\ \(0\)\
\-\ lp\\ \\(spinal\\ tap\\)\\ \\â\\€\\“\\ opening\\ pressure\\ of\\ 20\\.5\\ cmh2o\ \(0\)\
\-\ r\\ transverse\\ sinus\\ pressure\\ gradient\\ 13\\ mmhg\\ \\(normal\\ \\<4mmhg\\)\ \(0\)\
\-\ in\\ this\\ patient\\ had\\ stenosis\\ of\\ her\\ right\\ transverse\\ with\\ a\\ pressure\\ gradient\\ of\\ 13mm\\ hg\\ across\\ the\\ lesion\\.\\ \\ right\\ and\\ left\\ cerebral\\ angiography\\ followed\\ by\\ venogram\\ was\\ performed\\ to\\ better\\ identify\\ the\\ location\\ of\\ the\\ right\\ transverse\\ stenosis\\ and\\ surrounding\\ vessels\\ in\\ preparation\\ for\\ stenting\\.\\ \\ after\\ seeing\\ the\\ patient\\ several\\ times\\ before\\ in\\ clinic\\ for\\ an\\ adequate\\ pre\\-operation\\ work\\-up\\ she\\ was\\ scheduled\\ for\\ right\\ transverse\\ sinus\\ stenosis\\.\\ \\ access\\ was\\ obtained\\ from\\ the\\ left\\ common\\ femoral\\ vein\\ and\\ \\ angioplasty\\ of\\ the\\ right\\ transverse\\ sinus\\ was\\ performed\\ and\\ a\\ zilver\\ 7\\ x\\ 60\\ mm\\ stent\\ was\\ placed\\.\\ \\ status\\ post\\ surgery\\ the\\ patient\\ had\\ improved\\ symptoms\\ to\\ include\\ improved\\ vision\\ and\\ significant\\ decrease\\ in\\ pain\\ from\\ headaches\\.\\ \\ hope\\ to\\ continue\\ with\\ close\\ follow\\-up\\ with\\ patient\\.\ \(0\)\
\-\ \\â\\€\\¢\\ mr\\ venogram\\ \\(mrv\\)\\ showing\\ right\\ transverse\\ sinus\\ stenosis\\,\\ proximal\\ to\\ the\\ sigmoid\\ sinus\\ and\\ interntal\\ jugular\\ vein\\ \\(ijv\\)\\ junction\\.\ \(0\)\
\-\ \\â\\€\\¢\\ cerebral\\ catheter\\ arteriogram\\ \\&\\ venography\\ demonstrate\\ a\\ high\\-grade\\ right\\ transverse\\-sigmoid\\ sinus\\ stenosis\\,\\ distal\\ to\\ the\\ vein\\ of\\ labbe\\ connection\\.\\ \\ \\ the\\ stenosis\\ was\\ estimated\\ as\\ at\\ least\\ 80\\%\\ narrowing\\,\\ to\\ an\\ approximate\\ diameter\\ of\\ 1mm\\ with\\ a\\ pressure\\ gradient\\ across\\ the\\ stenosis\\ of\\ 13\\ mmhg\\.\ \(0\)\
\-\ \\â\\€\\¢\\ neurointerventional\\ radiology\\ endovascular\\ procedure\\ was\\ successful\\ with\\ a\\ balloon\\ angioplasty\\ and\\ stent\\ placement\\ across\\ the\\ stenosis\\ in\\ the\\ right\\ transverse\\ sinus\\.\ \(0\)\
\-\ pseudotumor\\ cerebri\\ w\\/\\ right\\ transverse\\ sinus\\ stenosis\ \(0\)\
\-\ \\â\\€\\¢\\ obstruction\\ of\\ venous\\ outflow\\,\\ eg\\,\\ venous\\ sinus\\ \\ stenosis\\/thrombosis\\,\\ jugular\\ vein\\ compression\ \(0\)\
\-\ \\â\\€\\¢\\ pseudotumor\\ cerebri\\ \\(idiopathic\\ intracranial\\ hypertension\\)\\ \ \(0\)\
\-\ \\â\\€\\¢\\ decreased\\ csf\\ absorption\\ \\(i\\.e\\.\\ arachnoid\\ granulation\\)\\ \ \(0\)\
\-\ \\â\\€\\¢\\ increased\\ cerebrospinal\\ fluid\\ \\(csf\\)\\ production\\ \\ \\(i\\.e\\.\\ choroid\\ plexus\\ papilloma\\)\\ \ \(0\)\
\-\ \\â\\€\\¢\\ intracranial\\ mass\\ lesions\\ \\(tumor\\,\\ abscess\\)\\ \ \(0\)\
\-\ \\â\\€\\¢\\ obstructive\\ hydrocephalus\ \(0\)\
\-\ 26\\ y\\.o\\.\\ obese\\ woman\\ with\\ a\\ hx\\ of\\ persistent\\ and\\ disabling\\ \\(8\\/10\\)\\ \\ global\\ headache\\ and\\ a\\ recent\\ onset\\ of\\ blurred\\ vision\ \(0\)\
\-\ pseudotumor\\ cerebri\\ also\\ known\\ as\\ idiopathic\\ intracranial\\ hypertension\\ \\(iih\\)\\ is\\ defined\\ by\\ a\\ class\\ clinical\\ symptoms\\ that\\ occur\\ in\\ the\\ setting\\ of\\ elevated\\ intracranial\\ pressure\\ and\\ normal\\ composition\\ of\\ cerebrospinal\\ fluid\\.\\ \\ classic\\ clinical\\ symptoms\\ include\\ headaches\\,\\ vision\\ changes\\ \\(including\\ vision\\ loss\\)\\,\\ hearing\\ changes\\ \\(tinnitus\\)\\,\\ and\\ the\\ disease\\ is\\ typically\\ seen\\ in\\ obese\\ females\\ of\\ childbearing\\ age\\.\\ \\ papilledema\\ is\\ the\\ most\\ common\\ physical\\ exam\\ finding\\,\\ but\\ visual\\ field\\ loss\\ and\\ sixth\\ nerve\\ palsy\\ may\\ also\\ be\\ seen\\ as\\ well\\.\\ \\ symptoms\\ may\\ become\\ severe\\ to\\ include\\ severe\\ disabling\\ headaches\\ and\\ complete\\ vision\\ loss\\.\\ \\ brain\\ computed\\ tomography\\ \\(ct\\)\\ and\\ magnetic\\ resonance\\ imaging\\ \\(mri\\)\\ are\\ typically\\ normal\\,\\ however\\,\\ the\\ following\\ findings\\ may\\ be\\ seen\\,\\ but\\ are\\ currently\\ not\\ diagnostic\\:\\ \\ \ \(0\)\
\-\ \\â\\€\\“\\ cerebral\\ venous\\ sinus\\ stenosis\ \(0\)\
\-\ \\â\\€\\“\\ flattening\\ of\\ the\\ posterior\\ sclera\\ \ \(0\)\
\-\ \\â\\€\\“\\ contrast\\ enhancement\\ of\\ the\\ prelaminar\\ optic\\ nerve\\ \\ \ \(0\)\
\-\ \\â\\€\\“\\ empty\\ sella\\ \ \(0\)\
\-\ \\â\\€\\“\\ distension\\ of\\ perioptic\\ subarachnoid\\ space\\ \\ \ \(0\)\
\-\ \\â\\€\\“\\ intraocular\\ protrusion\\ of\\ the\\ prelaminar\\ optic\\ nerve\\ \\ \ \(0\)\
\-\ \\â\\€\\“\\ orbital\\ optic\\ nerve\\ vertical\\ tortuosity\\ \\ \ \(0\)\
\-\ treatment\\ for\\ pseudotumor\\ cerebri\\ typically\\ includes\\ medical\\ management\\ with\\ acetazolamide\\ and\\ pain\\ control\\ for\\ headaches\\.\\ \\ furosemide\\ \\(lasix\\Â\\®\\)\\ and\\ corticosteroids\\ can\\ be\\ used\\ as\\ well\\.\\ \\ surgical\\ interventions\\ \\ include\\ lumbo\\-peritoneal\\ shunt\\ \\(lps\\)\\ and\\ ventriculo\\-peritoneal\\ shunt\\ \\(vps\\)\\,\\ which\\ often\\ produce\\ immediate\\ results\\.\\ \\ however\\,\\ about\\ 50\\%\\ there\\ is\\ a\\ regression\\ back\\ to\\ pseudotumor\\ symptoms\\,\\ more\\ often\\ with\\ lps\\ than\\ vps\\.\\ \ \(0\)\
\-\ optic\\ nerve\\ sheath\\ fenestration\\ is\\ also\\ sometimes\\ used\\ to\\ treat\\ visual\\ changes\\ or\\ loss\\ of\\ vision\\.\\ \\ venous\\ stenting\\ of\\ the\\ stenosis\\ of\\ the\\ cerebral\\ sinuses\\ is\\ a\\ relatively\\ new\\ way\\ of\\ treating\\ pseudotumor\\.\\ \\ current\\ articles\\ show\\ mixed\\ results\\,\\ but\\ some\\ studies\\ show\\ that\\ patients\\ with\\ pseudotumor\\ may\\ have\\ some\\ cerebral\\ sinus\\ stenosis\\ approximately\\ 30\\ \\â\\€\\“\\ 90\\%\\ of\\ the\\ time\\.\\ \\ whether\\ the\\ stenosis\\ is\\ a\\ primary\\ or\\ secondary\\ cause\\ is\\ unknown\\.\\ \\ \ \(0\)\
\-\ references\\:\ \(0\)\
\-\ friedman\\,\\ di\\,\\ jacobson\\,\\ dm\\.\\ \\â\\€\\œdiagnostic\\ criteria\\ for\\ idiopathic\\ intracranial\\ hypertension\\.\\â\\€\\\\ neurology\\ 2002\\;\\ 59\\:1492\\.\\ \ \(0\)\
\-\ mccarthy\\,\\ kd\\,\\ viernstein\\,\\ l\\.\\ \\â\\€\\œlong\\-term\\ intracranial\\ pressure\\ recording\\ in\\ the\\ management\\ of\\ pseudotumor\\ cerebri\\.\\â\\€\\\\ j\\ pharmacol\\ exp\\ ther\\ 1974\\;\\ 189\\:194\\.\\ \ \(0\)\
\-\ corbett\\,\\ jj\\,\\ thompson\\,\\ hs\\.\\ \\â\\€\\œthe\\ rational\\ management\\ of\\ idiopathic\\ intracranial\\ hypertension\\.\\â\\€\\\\ arch\\ neurol\\ 1989\\;\\ 46\\:1049\\.\\ \ \(0\)\
\-\ donnet\\,\\ a\\,\\ metellus\\,\\ p\\,\\ levrier\\,\\ o\\,\\ et\\ al\\.\\ \\â\\€\\œendovascular\\ treatment\\ of\\ idiopathic\\ intracranial\\ hypertension\\:\\ clinical\\ and\\ radiologic\\ outcome\\ of\\ 10\\ consecutive\\ patients\\.\\â\\€\\\\ neurology\\ 2008\\;\\ 70\\:641\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ stenosis\\:\\ 0\\.05543561487491436\ \(0\)\
\-\ pseudotumor\\:\\ 0\\.05038794815855906\ \(0\)\
\-\ \\â\\€\\“\\:\\ 0\\.04409088677645156\ \(0\)\
\-\ sinus\\:\\ 0\\.04379203651728257\ \(0\)\
\-\ intracranial\\:\\ 0\\.036805215153016074\ \(0\)\
\-\ transverse\\:\\ 0\\.0349192019785987\ \(0\)\
\-\ vision\\:\\ 0\\.03017567368288598\ \(0\)\
\-\ pressure\\:\\ 0\\.029925516393320223\ \(0\)\
\-\ cerebri\\:\\ 0\\.02872593423499899\ \(0\)\
\-\ idiopathic\\:\\ 0\\.024812340752473717\ \(0\)\
\-\ prelaminar\\:\\ 0\\.022459919551507\ \(0\)\
\-\ lps\\:\\ 0\\.022459919551507\ \(0\)\
\-\ vps\\:\\ 0\\.022459919551507\ \(0\)\
\-\ hypertension\\.\\:\\ 0\\.022459919551507\ \(0\)\
\-\ cmh2o\\:\\ 0\\.02069393947364727\ \(0\)\
\-\ optic\\:\\ 0\\.020156463794164716\ \(0\)\
\-\ gradient\\:\\ 0\\.019788276169070494\ \(0\)\
\-\ nerve\\:\\ 0\\.019611121824759912\ \(0\)\
\-\ cerebral\\:\\ 0\\.01885634714499408\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.017965769636131196\ \(0\)\
\-\ across\\:\\ 0\\.017453591778027282\ \(0\)\
\-\ disabling\\:\\ 0\\.0171619793179278\ \(0\)\
\-\ headaches\\:\\ 0\\.01664429217361161\ \(0\)\
\-\ \\(\\:\\ 0\\.016563708372470686\ \(0\)\
\-\ \\)\\:\\ 0\\.016361373831897442\ \(0\)\
\-\ \\â\\€\\œ\\:\\ 0\\.01626242505874731\ \(0\)\
\-\ \\â\\€\\\\:\\ 0\\.016171268040908966\ \(0\)\
\-\ cerebrospinal\\:\\ 0\\.015925016729948945\ \(0\)\
\-\ venous\\:\\ 0\\.015805277036724224\ \(0\)\
\-\ vein\\:\\ 0\\.015755074252301233\ \(0\)\
\-\ venogram\\:\\ 0\\.01524154160486696\ \(0\)\
\-\ stenting\\:\\ 0\\.01415903665208921\ \(0\)\
\-\ angioplasty\\:\\ 0\\.01397022653195234\ \(0\)\
\-\ endovascular\\:\\ 0\\.013630019162208334\ \(0\)\
\-\ symptoms\\:\\ 0\\.01356469730508369\ \(0\)\
\-\ papilledema\\:\\ 0\\.013551620031847178\ \(0\)\
\-\ mmhg\\:\\ 0\\.013260128691266939\ \(0\)\
\-\ neurology\\:\\ 0\\.013260128691266939\ \(0\)\
\-\ ocular\\:\\ 0\\.013192184112713662\ \(0\)\
\-\ hypertension\\:\\ 0\\.012874322492866961\ \(0\)\
\-\ loss\\:\\ 0\\.0126393078851895\ \(0\)\
\-\ obese\\:\\ 0\\.012596987039639764\ \(0\)\
\-\ jugular\\:\\ 0\\.012492981958059495\ \(0\)\
\-\ management\\:\\ 0\\.012323050102378247\ \(0\)\
\-\ stent\\:\\ 0\\.012250153474481598\ \(0\)\
\-\ include\\:\\ 0\\.012214794843466428\ \(0\)\
\-\ i\\.e\\:\\ 0\\.011635727852018187\ \(0\)\
\-\ typically\\:\\ 0\\.01152774179429034\ \(0\)\
\-\ \\,\\:\\ 0\\.011380168359325456\ \(0\)\
\-\ shunt\\:\\ 0\\.011263870749793781\ \(0\)\
\-\ 4mmhg\\:\\ 0\\.0112299597757535\ \(0\)\
\-\ zilver\\:\\ 0\\.0112299597757535\ \(0\)\
\-\ interntal\\:\\ 0\\.0112299597757535\ \(0\)\
\-\ transverse\\-sigmoid\\:\\ 0\\.0112299597757535\ \(0\)\
\-\ labbe\\:\\ 0\\.0112299597757535\ \(0\)\
\-\ stenosis\\/thrombosis\\:\\ 0\\.0112299597757535\ \(0\)\
\-\ perioptic\\:\\ 0\\.0112299597757535\ \(0\)\
\-\ lasix\\Â\\®\\:\\ 0\\.0112299597757535\ \(0\)\
\-\ lumbo\\-peritoneal\\:\\ 0\\.0112299597757535\ \(0\)\
\-\ friedman\\:\\ 0\\.0112299597757535\ \(0\)\
\-\ 59\\:1492\\.\\:\\ 0\\.0112299597757535\ \(0\)\
\-\ mccarthy\\:\\ 0\\.0112299597757535\ \(0\)\
\-\ viernstein\\:\\ 0\\.0112299597757535\ \(0\)\
\-\ cerebri\\.\\:\\ 0\\.0112299597757535\ \(0\)\
\-\ 189\\:194\\.\\:\\ 0\\.0112299597757535\ \(0\)\
\-\ corbett\\:\\ 0\\.0112299597757535\ \(0\)\
\-\ 46\\:1049\\.\\:\\ 0\\.0112299597757535\ \(0\)\
\-\ donnet\\:\\ 0\\.0112299597757535\ \(0\)\
\-\ metellus\\:\\ 0\\.0112299597757535\ \(0\)\
\-\ levrier\\:\\ 0\\.0112299597757535\ \(0\)\
\-\ 70\\:641\\:\\ 0\\.0112299597757535\ \(0\)\
\-\ improved\\:\\ 0\\.010370920498352225\ \(0\)\
\-\ pre\\-operation\\:\\ 0\\.010346969736823634\ \(0\)\
\-\ iih\\:\\ 0\\.010346969736823634\ \(0\)\
\-\ articles\\:\\ 0\\.010346969736823634\ \(0\)\
\-\ patients\\.\\:\\ 0\\.010346969736823634\ \(0\)\
\-\ right\\:\\ 0\\.010337178830565286\ \(0\)\
\-\ \\;\\:\\ 0\\.010320617520777547\ \(0\)\
\-\ clinical\\:\\ 0\\.010048317707258616\ \(0\)\
\-\ visual\\:\\ 0\\.009869747774158456\ \(0\)\
\-\ 13\\:\\ 0\\.009833608576726719\ \(0\)\
\-\ 20\\.5\\:\\ 0\\.009830453675539348\ \(0\)\
\-\ ijv\\:\\ 0\\.009830453675539348\ \(0\)\
\-\ acetazolamide\\:\\ 0\\.009830453675539348\ \(0\)\
\-\ di\\:\\ 0\\.009830453675539348\ \(0\)\
\-\ recording\\:\\ 0\\.009830453675539348\ \(0\)\
\-\ pharmacol\\:\\ 0\\.009830453675539348\ \(0\)\
\-\ 1974\\:\\ 0\\.009830453675539348\ \(0\)\
\-\ thompson\\:\\ 0\\.009830453675539348\ \(0\)\
\-\ hs\\:\\ 0\\.009830453675539348\ \(0\)\
\-\ rational\\:\\ 0\\.009830453675539348\ \(0\)\
\-\ may\\:\\ 0\\.009550717803302541\ \(0\)\
\-\ neurointerventional\\:\\ 0\\.009463979697893768\ \(0\)\
\-\ ventriculo\\-peritoneal\\:\\ 0\\.009463979697893768\ \(0\)\
\-\ jacobson\\:\\ 0\\.009463979697893768\ \(0\)\
\-\ exp\\:\\ 0\\.009463979697893768\ \(0\)\
\-\ changes\\:\\ 0\\.00935941901745883\ \(0\)\
\-\ consecutive\\:\\ 0\\.009179720396856557\ \(0\)\
\-\ csf\\:\\ 0\\.009091705354919776\ \(0\)\
\-\ fenestration\\:\\ 0\\.008947463636609481\ \(0\)\
\-\ kd\\:\\ 0\\.008947463636609481\ \(0\)\
\-\ was\\:\\ 0\\.008812665803179373\ \(0\)\
\-\ results\\:\\ 0\\.00878864308011375\ \(0\)\
\-\ 13mm\\:\\ 0\\.008751093343835904\ \(0\)\
\-\ composition\\:\\ 0\\.008751093343835904\ \(0\)\
\-\ childbearing\\:\\ 0\\.008751093343835904\ \(0\)\
\-\ jj\\:\\ 0\\.008751093343835904\ \(0\)\
\-\ diagnostic\\:\\ 0\\.008627191834425623\ \(0\)\
\-\ hope\\:\\ 0\\.0085809896589639\ \(0\)\
\-\ venography\\:\\ 0\\.0085809896589639\ \(0\)\
\-\ 1mm\\:\\ 0\\.0085809896589639\ \(0\)\
\-\ furosemide\\:\\ 0\\.0085809896589639\ \(0\)\
\-\ ther\\:\\ 0\\.0085809896589639\ \(0\)\
\-\ neurol\\:\\ 0\\.0085809896589639\ \(0\)\
\-\ used\\:\\ 0\\.008352061546364233\ \(0\)\
\-\ arteriogram\\:\\ 0\\.00829673035792669\ \(0\)\
\-\ intraocular\\:\\ 0\\.00829673035792669\ \(0\)\
\-\ preparation\\:\\ 0\\.008175316116137742\ \(0\)\
\-\ seeing\\:\\ 0\\.008175316116137742\ \(0\)\
\-\ 8\\/10\\:\\ 0\\.008175316116137742\ \(0\)\
\-\ 1989\\:\\ 0\\.008175316116137742\ \(0\)\
\-\ approximate\\:\\ 0\\.008064473597679615\ \(0\)\
\-\ absorption\\:\\ 0\\.008064473597679615\ \(0\)\
\-\ granulation\\:\\ 0\\.008064473597679615\ \(0\)\
\-\ tortuosity\\:\\ 0\\.008064473597679615\ \(0\)\
\-\ tap\\:\\ 0\\.007868103304906037\ \(0\)\
\-\ \\&\\:\\ 0\\.007646848132844411\ \(0\)\
\-\ lp\\:\\ 0\\.00762077080243348\ \(0\)\
\-\ \\%\\:\\ 0\\.007617787388583468\ \(0\)\
\-\ hg\\:\\ 0\\.007547957536395329\ \(0\)\
\-\ sclera\\:\\ 0\\.0074790820952866975\ \(0\)\
\-\ high\\-grade\\:\\ 0\\.007413740318996824\ \(0\)\
\-\ tinnitus\\:\\ 0\\.007351587243621751\ \(0\)\
\-\ mrv\\:\\ 0\\.0072923260772078755\ \(0\)\
\-\ blurred\\:\\ 0\\.0072923260772078755\ \(0\)\
\-\ outflow\\:\\ 0\\.007235699628073055\ \(0\)\
\-\ global\\:\\ 0\\.007235699628073055\ \(0\)\
\-\ class\\:\\ 0\\.007235699628073055\ \(0\)\
\-\ interventions\\:\\ 0\\.007235699628073055\ \(0\)\
\-\ sixth\\:\\ 0\\.007181483558749748\ \(0\)\
\-\ empty\\:\\ 0\\.007079518326044605\ \(0\)\
\-\ regression\\:\\ 0\\.007079518326044605\ \(0\)\
\-\ but\\:\\ 0\\.006964980768281036\ \(0\)\
\-\ often\\:\\ 0\\.006946429422980006\ \(0\)\
\-\ access\\:\\ 0\\.0068972242577125375\ \(0\)\
\-\ dm\\:\\ 0\\.0068972242577125375\ \(0\)\
\-\ opening\\:\\ 0\\.006737780763503613\ \(0\)\
\-\ treating\\:\\ 0\\.006737780763503613\ \(0\)\
\-\ connection\\:\\ 0\\.006700853964938961\ \(0\)\
\-\ severe\\:\\ 0\\.0066988784715057426\ \(0\)\
\-\ show\\:\\ 0\\.006683199833099684\ \(0\)\
\-\ corticosteroids\\:\\ 0\\.0066300643456334695\ \(0\)\
\-\ o\\:\\ 0\\.0066300643456334695\ \(0\)\
\-\ some\\:\\ 0\\.00661128217545671\ \(0\)\
\-\ production\\:\\ 0\\.006596092056356831\ \(0\)\
\-\ as\\:\\ 0\\.006586382195638867\ \(0\)\
\-\ eg\\:\\ 0\\.006530750280066958\ \(0\)\
\-\ identify\\:\\ 0\\.006499294722626994\ \(0\)\
\-\ outcome\\:\\ 0\\.006499294722626994\ \(0\)\
\-\ seen\\:\\ 0\\.006453353942933848\ \(0\)\
\-\ also\\:\\ 0\\.006438036663707585\ \(0\)\
\-\ balloon\\:\\ 0\\.006409336038278008\ \(0\)\
\-\ resonance\\:\\ 0\\.006380708196428253\ \(0\)\
\-\ vertical\\:\\ 0\\.006380708196428253\ \(0\)\
\-\ way\\:\\ 0\\.006380708196428253\ \(0\)\
\-\ distension\\:\\ 0\\.006325313149371261\ \(0\)\
\-\ estimated\\:\\ 0\\.006298493519819882\ \(0\)\
\-\ 2008\\:\\ 0\\.006298493519819882\ \(0\)\
\-\ sella\\:\\ 0\\.006272226911918307\ \(0\)\
\-\ protrusion\\:\\ 0\\.006272226911918307\ \(0\)\
\-\ magnetic\\:\\ 0\\.006246490979029747\ \(0\)\
\-\ fluid\\:\\ 0\\.006187615553130836\ \(0\)\
\-\ work\\-up\\:\\ 0\\.006148451436181176\ \(0\)\
\-\ treat\\:\\ 0\\.006148451436181176\ \(0\)\
\-\ performed\\:\\ 0\\.006070263264273424\ \(0\)\
\-\ a\\:\\ 0\\.006062672129711102\ \(0\)\
\-\ however\\:\\ 0\\.006062084218081708\ \(0\)\
\-\ females\\:\\ 0\\.0060574209088153875\ \(0\)\
\-\ palsy\\:\\ 0\\.0060356445605869785\ \(0\)\
\-\ produce\\:\\ 0\\.0060356445605869785\ \(0\)\
\-\ long\\-term\\:\\ 0\\.006014234218782672\ \(0\)\
\-\ sheath\\:\\ 0\\.005993177783176034\ \(0\)\
\-\ criteria\\:\\ 0\\.0059520811434076\ \(0\)\
\-\ 2002\\:\\ 0\\.0059520811434076\ \(0\)\
\-\ flattening\\:\\ 0\\.0059320195421743\ \(0\)\
\-\ continue\\:\\ 0\\.005873663445319149\ \(0\)\
\-\ whether\\:\\ 0\\.005854790724573747\ \(0\)\
\-\ adequate\\:\\ 0\\.005836193527858902\ \(0\)\
\-\ tomography\\:\\ 0\\.0058178639260090936\ \(0\)\
\-\ successful\\:\\ 0\\.005799794327293226\ \(0\)\
\-\ 46\\:\\ 0\\.00576440634753899\ \(0\)\
\-\ \\:\\:\\ 0\\.005759362119697656\ \(0\)\
\-\ computed\\:\\ 0\\.005747074306703602\ \(0\)\
\-\ is\\:\\ 0\\.005730351881627777\ \(0\)\
\-\ common\\:\\ 0\\.005697496081417572\ \(0\)\
\-\ immediate\\:\\ 0\\.005696449684220145\ \(0\)\
\-\ radiologic\\:\\ 0\\.005663784167515257\ \(0\)\
\-\ w\\/\\:\\ 0\\.00564776024113709\ \(0\)\
\-\ better\\:\\ 0\\.0056163046836971275\ \(0\)\
\-\ obstructive\\:\\ 0\\.005600863460089044\ \(0\)\
\-\ sinuses\\:\\ 0\\.005600863460089044\ \(0\)\
\-\ field\\:\\ 0\\.005585607165762017\ \(0\)\
\-\ p\\:\\ 0\\.005585607165762017\ \(0\)\
\-\ for\\:\\ 0\\.005572801136122663\ \(0\)\
\-\ choroid\\:\\ 0\\.005555632009825465\ \(0\)\
\-\ sigmoid\\:\\ 0\\.005540904847531101\ \(0\)\
\-\ sometimes\\:\\ 0\\.005540904847531101\ \(0\)\
\-\ setting\\:\\ 0\\.005497718157498386\ \(0\)\
\-\ scheduled\\:\\ 0\\.005483641933056877\ \(0\)\
\-\ angiography\\:\\ 0\\.005469719550213322\ \(0\)\
\-\ arachnoid\\:\\ 0\\.005469719550213322\ \(0\)\
\-\ papilloma\\:\\ 0\\.005469719550213322\ \(0\)\
\-\ least\\:\\ 0\\.005455947682564639\ \(0\)\
\-\ hx\\:\\ 0\\.005389236872988441\ \(0\)\
\-\ hearing\\:\\ 0\\.005363500940099881\ \(0\)\
\-\ close\\:\\ 0\\.005313538248184873\ \(0\)\
\-\ plexus\\:\\ 0\\.0052892730316616956\ \(0\)\
\-\ subarachnoid\\:\\ 0\\.0052892730316616956\ \(0\)\
\-\ times\\:\\ 0\\.00527731157898674\ \(0\)\
\-\ catheter\\:\\ 0\\.005230558245419317\ \(0\)\
\-\ become\\:\\ 0\\.005185460249176112\ \(0\)\
\-\ orbital\\:\\ 0\\.0051634961645461675\ \(0\)\
\-\ 90\\:\\ 0\\.0051312441798528055\ \(0\)\
\-\ 80\\:\\ 0\\.005120672456521983\ \(0\)\
\-\ normal\\:\\ 0\\.005119538043053889\ \(0\)\
\-\ current\\:\\ 0\\.005099788622412841\ \(0\)\
\-\ 26\\:\\ 0\\.005039115948541179\ \(0\)\
\-\ be\\:\\ 0\\.005036012955454507\ \(0\)\
\-\ showing\\:\\ 0\\.005009829938063856\ \(0\)\
\-\ decrease\\:\\ 0\\.0049812020962141\ \(0\)\
\-\ control\\:\\ 0\\.004962468150494743\ \(0\)\
\-\ l\\:\\ 0\\.004962468150494743\ \(0\)\
\-\ r\\:\\ 0\\.004944005720809944\ \(0\)\
\-\ well\\:\\ 0\\.004925047013932869\ \(0\)\
\-\ j\\:\\ 0\\.0049168042883633595\ \(0\)\
\-\ arch\\:\\ 0\\.004898987419605729\ \(0\)\
\-\ to\\:\\ 0\\.004896322262403664\ \(0\)\
\-\ clinic\\:\\ 0\\.004864084267773737\ \(0\)\
\-\ exam\\:\\ 0\\.0047827616304446825\ \(0\)\
\-\ mixed\\:\\ 0\\.00478079412858539\ \(0\)\
\-\ 60\\:\\ 0\\.004748945335967024\ \(0\)\
\-\ had\\:\\ 0\\.004697706545836199\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.0046800698948583925\ \(0\)\
\-\ relatively\\:\\ 0\\.0046579148086012346\ \(0\)\
\-\ al\\:\\ 0\\.004614728118568519\ \(0\)\
\-\ before\\:\\ 0\\.004607670563949901\ \(0\)\
\-\ radiology\\:\\ 0\\.004600651894127009\ \(0\)\
\-\ defined\\:\\ 0\\.004586729511283455\ \(0\)\
\-\ diameter\\:\\ 0\\.0045798249667365265\ \(0\)\
\-\ the\\:\\ 0\\.004578957200374867\ \(0\)\
\-\ junction\\:\\ 0\\.004559333071511527\ \(0\)\
\-\ procedure\\:\\ 0\\.004559333071511527\ \(0\)\
\-\ references\\:\\ 0\\.004525895840842818\ \(0\)\
\-\ et\\:\\ 0\\.004455284624359595\ \(0\)\
\-\ placement\\:\\ 0\\.0044183578257949415\ \(0\)\
\-\ treatment\\:\\ 0\\.0044066674129958905\ \(0\)\
\-\ placed\\:\\ 0\\.004406282992731828\ \(0\)\
\-\ includes\\:\\ 0\\.004388382669858389\ \(0\)\
\-\ vessels\\:\\ 0\\.0043824713583214435\ \(0\)\
\-\ narrowing\\:\\ 0\\.004364900247324837\ \(0\)\
\-\ patient\\:\\ 0\\.0043647996479815945\ \(0\)\
\-\ persistent\\:\\ 0\\.004341842869434878\ \(0\)\
\-\ currently\\:\\ 0\\.004313595917212812\ \(0\)\
\-\ in\\:\\ 0\\.004294494065123617\ \(0\)\
\-\ unknown\\:\\ 0\\.004248254140922938\ \(0\)\
\-\ \\<\\:\\ 0\\.004201357359874892\ \(0\)\
\-\ about\\:\\ 0\\.004196251600132804\ \(0\)\
\-\ 30\\:\\ 0\\.004186101065547866\ \(0\)\
\-\ 7\\:\\ 0\\.004171025323322385\ \(0\)\
\-\ classic\\:\\ 0\\.004171025323322385\ \(0\)\
\-\ of\\:\\ 0\\.004155549582603409\ \(0\)\
\-\ femoral\\:\\ 0\\.004141398747316948\ \(0\)\
\-\ 50\\:\\ 0\\.004141398747316948\ \(0\)\
\-\ and\\:\\ 0\\.004127595035898003\ \(0\)\
\-\ occur\\:\\ 0\\.0040841358328427245\ \(0\)\
\-\ compression\\:\\ 0\\.004074837358343855\ \(0\)\
\-\ studies\\:\\ 0\\.004065606264686827\ \(0\)\
\-\ mm\\:\\ 0\\.004002796378082809\ \(0\)\
\-\ including\\:\\ 0\\.003930469606360412\ \(0\)\
\-\ spinal\\:\\ 0\\.0038978040896555234\ \(0\)\
\-\ status\\:\\ 0\\.0038857672881294947\ \(0\)\
\-\ obtained\\:\\ 0\\.0038698931219666773\ \(0\)\
\-\ obstruction\\:\\ 0\\.0038387261765470515\ \(0\)\
\-\ complete\\:\\ 0\\.0038310521452051645\ \(0\)\
\-\ location\\:\\ 0\\.003797079855928526\ \(0\)\
\-\ new\\:\\ 0\\.003793360480000711\ \(0\)\
\-\ that\\:\\ 0\\.0037604604549269383\ \(0\)\
\-\ headache\\:\\ 0\\.0037388349523131185\ \(0\)\
\-\ elevated\\:\\ 0\\.003693396638673965\ \(0\)\
\-\ cause\\:\\ 0\\.003683137103887855\ \(0\)\
\-\ 10\\:\\ 0\\.00366958500426358\ \(0\)\
\-\ recent\\:\\ 0\\.0036595147118978306\ \(0\)\
\-\ followed\\:\\ 0\\.003649523403030282\ \(0\)\
\-\ by\\:\\ 0\\.003625148798076114\ \(0\)\
\-\ space\\:\\ 0\\.003600709563154948\ \(0\)\
\-\ x\\:\\ 0\\.00359116730617513\ \(0\)\
\-\ back\\:\\ 0\\.00359116730617513\ \(0\)\
\-\ surrounding\\:\\ 0\\.00357855447689779\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.0035414483967410723\ \(0\)\
\-\ finding\\:\\ 0\\.003508358605144562\ \(0\)\
\-\ several\\:\\ 0\\.0034994813193915766\ \(0\)\
\-\ mr\\:\\ 0\\.0034588528305050112\ \(0\)\
\-\ known\\:\\ 0\\.003444651063011235\ \(0\)\
\-\ abscess\\:\\ 0\\.0034418296103621237\ \(0\)\
\-\ onset\\:\\ 0\\.0034362053833441398\ \(0\)\
\-\ post\\:\\ 0\\.003427815328754514\ \(0\)\
\-\ approximately\\:\\ 0\\.003367920798159978\ \(0\)\
\-\ medical\\:\\ 0\\.0033494392357528713\ \(0\)\
\-\ age\\:\\ 0\\.003313261561202938\ \(0\)\
\-\ brain\\:\\ 0\\.0032756070360544735\ \(0\)\
\-\ her\\:\\ 0\\.0032731358706814466\ \(0\)\
\-\ proximal\\:\\ 0\\.003268207874786006\ \(0\)\
\-\ decreased\\:\\ 0\\.0032366323601586743\ \(0\)\
\-\ from\\:\\ 0\\.0032265878042145534\ \(0\)\
\-\ primary\\:\\ 0\\.0032246933285295493\ \(0\)\
\-\ y\\.o\\:\\ 0\\.003141884627498981\ \(0\)\
\-\ following\\:\\ 0\\.0030895258049696154\ \(0\)\
\-\ time\\:\\ 0\\.003074651244890844\ \(0\)\
\-\ she\\:\\ 0\\.003055778524145442\ \(0\)\
\-\ secondary\\:\\ 0\\.003043350275807398\ \(0\)\
\-\ an\\:\\ 0\\.003010611119196764\ \(0\)\
\-\ are\\:\\ 0\\.0029678315223684117\ \(0\)\
\-\ distal\\:\\ 0\\.002959590559166913\ \(0\)\
\-\ significant\\:\\ 0\\.0029271938229990103\ \(0\)\
\-\ enhancement\\:\\ 0\\.0029178200842331667\ \(0\)\
\-\ lesions\\:\\ 0\\.002914089816998659\ \(0\)\
\-\ than\\:\\ 0\\.0028522915349277374\ \(0\)\
\-\ patients\\:\\ 0\\.0028172924832688224\ \(0\)\
\-\ more\\:\\ 0\\.0027225175914804664\ \(0\)\
\-\ physical\\:\\ 0\\.002670707349785017\ \(0\)\
\-\ increased\\:\\ 0\\.0026630379385982872\ \(0\)\
\-\ pain\\:\\ 0\\.0026588743121802156\ \(0\)\
\-\ surgery\\:\\ 0\\.002643310910013089\ \(0\)\
\-\ or\\:\\ 0\\.0025516503158311016\ \(0\)\
\-\ imaging\\:\\ 0\\.002550412515230067\ \(0\)\
\-\ tumor\\:\\ 0\\.0025378755434532626\ \(0\)\
\-\ woman\\:\\ 0\\.0025145260477565682\ \(0\)\
\-\ most\\:\\ 0\\.002513165785640861\ \(0\)\
\-\ posterior\\:\\ 0\\.002509093692614584\ \(0\)\
\-\ demonstrate\\:\\ 0\\.0025050345749465484\ \(0\)\
\-\ mri\\:\\ 0\\.0025009883502097067\ \(0\)\
\-\ can\\:\\ 0\\.0024690730604701523\ \(0\)\
\-\ contrast\\:\\ 0\\.002436656925869943\ \(0\)\
\-\ left\\:\\ 0\\.0024359369917781267\ \(0\)\
\-\ have\\:\\ 0\\.0023572459597007538\ \(0\)\
\-\ findings\\:\\ 0\\.0023169897271209674\ \(0\)\
\-\ surgical\\:\\ 0\\.0022881805990464374\ \(0\)\
\-\ after\\:\\ 0\\.0022522308313493024\ \(0\)\
\-\ lesion\\:\\ 0\\.002217267803822235\ \(0\)\
\-\ which\\:\\ 0\\.0020320313213280875\ \(0\)\
\-\ disease\\:\\ 0\\.0017792834919945276\ \(0\)\
\-\ there\\:\\ 0\\.0016200198171528518\ \(0\)\
\-\ not\\:\\ 0\\.0015730174162317647\ \(0\)\
\-\ ct\\:\\ 0\\.001522679813238271\ \(0\)\
\-\ mass\\:\\ 0\\.0015139630661752414\ \(0\)\
\-\ at\\:\\ 0\\.0014748575195307426\ \(0\)\
\-\ \\.\\:\\ 0\\.0013566701693253354\ \(0\)\
\-\ with\\:\\ 0\\.0013414491526229397\ \(0\)\
\-\ this\\:\\ 0\\.0012243786156867936\ \(0\)\
